{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:49:55Z","timestamp":1791596995709,"version":"4.3.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05434-4","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:56:36Z","timestamp":1791550596000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Institutional adherence, complication rates, and intravesical recurrence with intraoperative mitomycin C during radical nephroureterectomy"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8285-4020","authenticated-orcid":false,"given":"Stine H.","family":"Reeler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1416-2153","authenticated-orcid":false,"given":"Naomi","family":"Nadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5161-5302","authenticated-orcid":false,"given":"Rose B.","family":"Laursen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4347-739X","authenticated-orcid":false,"given":"J\u00f8rgen B.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8865-6968","authenticated-orcid":false,"given":"Frederik F.","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8005-3545","authenticated-orcid":false,"given":"Juan L.","family":"V\u00e1squez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"key":"5434_CR1","doi-asserted-by":"publisher","DOI":"10.1080\/21681805.2019.1710562","author":"NH Azawi","year":"2020","unstructured":"Azawi NH, N\u00e6raa SH, Subhi Y et al (2020) Oncological outcomes of radical nephroureterectomy for upper urinary tract urothelial neoplasia in Denmark. Scand J Urol. https:\/\/doi.org\/10.1080\/21681805.2019.1710562","journal-title":"Scand J Urol"},{"key":"5434_CR2","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1007\/s00345-020-03576-3","volume":"39","author":"B Alm\u00e5s","year":"2021","unstructured":"Alm\u00e5s B, Halvorsen OJ, Johannesen TB, Beisland C (2021) Higher than expected and significantly increasing incidence of upper tract urothelial carcinoma. A population based study. World J Urol 39:3385\u20133391. https:\/\/doi.org\/10.1007\/s00345-020-03576-3","journal-title":"World J Urol"},{"key":"5434_CR3","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.eururo.2025.02.023","volume":"87","author":"A Masson-Lecomte","year":"2025","unstructured":"Masson-Lecomte A, Birtle A, Pradere B et al (2025) European Association of Urology Guidelines on upper urinary tract urothelial carcinoma: summary of the 2025 update. Eur Urol 87:697\u2013716. https:\/\/doi.org\/10.1016\/j.eururo.2025.02.023","journal-title":"Eur Urol"},{"key":"5434_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.euros.2023.01.004","volume":"49","author":"LS Mertens","year":"2023","unstructured":"Mertens LS, Sharma V, Matin SF et al (2023) Bladder recurrence following upper tract surgery for urothelial carcinoma: a contemporary review of risk factors and management strategies. Eur Urol Open Sci 49:60\u201366. https:\/\/doi.org\/10.1016\/j.euros.2023.01.004","journal-title":"Eur Urol Open Sci"},{"key":"5434_CR5","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.eururo.2011.05.064","volume":"60","author":"T O\u2019Brien","year":"2011","unstructured":"O\u2019Brien T, Ray E, Singh R et al (2011) Prevention of bladder tumours after Nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C trial). Eur Urol 60:703\u2013710. https:\/\/doi.org\/10.1016\/j.eururo.2011.05.064","journal-title":"Eur Urol"},{"key":"5434_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.euros.2020.10.003","volume":"22","author":"T-R Dob\u00e9","year":"2020","unstructured":"Dob\u00e9 T-R, Califano G, von Rundstedt F-C et al (2020) Postoperative chemotherapy bladder instillation after radical nephroureterectomy: results of a European survey from the Young Academic Urologist Urothelial Cancer Group. Eur Urol Open Sci 22:45\u201350. https:\/\/doi.org\/10.1016\/j.euros.2020.10.003","journal-title":"Eur Urol Open Sci"},{"key":"5434_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-024-01515-7","volume":"24","author":"K Oedorf","year":"2024","unstructured":"Oedorf K, Haug ES, Liedberg F et al (2024) Perioperative management of upper tract urothelial carcinoma in the Nordic countries. BMC Urol 24:132. https:\/\/doi.org\/10.1186\/s12894-024-01515-7","journal-title":"BMC Urol"},{"key":"5434_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.euros.2021.09.013","volume":"34","author":"N Nadler","year":"2021","unstructured":"Nadler N, Oedorf K, Jensen JB, Azawi N (2021) Intraoperative mitomycin C bladder instillation during radical nephroureterectomy is feasible and safe. Eur Urol Open Sci 34:41\u201346. https:\/\/doi.org\/10.1016\/j.euros.2021.09.013","journal-title":"Eur Urol Open Sci"},{"key":"5434_CR9","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.eururo.2011.10.033","volume":"61","author":"D Mitropoulos","year":"2012","unstructured":"Mitropoulos D, Artibani W, Graefen M et al (2012) Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU guidelines panel assessment and recommendations. Eur Urol 61:341\u2013349. https:\/\/doi.org\/10.1016\/j.eururo.2011.10.033","journal-title":"Eur Urol"},{"key":"5434_CR10","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.eururo.2024.12.006","volume":"87","author":"T Van Doeveren","year":"2025","unstructured":"Van Doeveren T, Remmers S, Boev\u00e9 ER et al (2025) Intravesical instillation of chemotherapy before radical surgery for upper urinary tract urothelial carcinoma: the REBACARE trial. Eur Urol 87:444\u2013452. https:\/\/doi.org\/10.1016\/j.eururo.2024.12.006","journal-title":"Eur Urol"},{"key":"5434_CR11","unstructured":"Regulation (EU) 2016\/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95\/46\/EC (General Data Protection Regulation)"},{"key":"5434_CR12","doi-asserted-by":"publisher","first-page":"113.e1","DOI":"10.1016\/j.urolonc.2016.10.016","volume":"35","author":"DD Lu","year":"2017","unstructured":"Lu DD, Boorjian SA, Raman JD (2017) Intravesical chemotherapy use after radical nephroureterectomy: a national survey of urologic oncologists. Urol Oncol 35:113.e1-113.e7. https:\/\/doi.org\/10.1016\/j.urolonc.2016.10.016","journal-title":"Urol Oncol"},{"key":"5434_CR13","doi-asserted-by":"publisher","first-page":"452.e17","DOI":"10.1016\/j.urolonc.2022.06.006","volume":"40","author":"AP Kenigsberg","year":"2022","unstructured":"Kenigsberg AP, Carpinito G, Gold SA et al (2022) Practice trends for perioperative intravesical chemotherapy in upper tract urothelial carcinoma: low but increasing utilization during minimally invasive nephroureterectomy. Urol Oncol 40:452.e17-452.e23. https:\/\/doi.org\/10.1016\/j.urolonc.2022.06.006","journal-title":"Urol Oncol"},{"key":"5434_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.23736\/S2724-6051.26.06684-X","volume":"78","author":"M Ferriero","year":"2026","unstructured":"Ferriero M, Tuderti G, Proietti F et al (2026) Real-world multicenter adherence to international guidelines in the management of upper tract urothelial carcinoma: insights from the ROBUUST 2.0 Registry. Minerva Urol Nephrol 78:241\u2013248. https:\/\/doi.org\/10.23736\/S2724-6051.26.06684-X","journal-title":"Minerva Urol Nephrol"},{"key":"5434_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2025.110396","volume":"51","author":"F Di Maida","year":"2025","unstructured":"Di Maida F, Bravi CA, De Groote R et al (2025) Robot-assisted radical nephroureterectomy for locally advanced upper tract urothelial carcinoma: a multicenter study by the Junior ERUS\/YAU Working Group on Robot-assisted Surgery. Eur J Surg Oncol 51:110396. https:\/\/doi.org\/10.1016\/j.ejso.2025.110396","journal-title":"Eur J Surg Oncol"},{"key":"5434_CR16","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/bju.15162","volume":"126","author":"A Gulamhusein","year":"2020","unstructured":"Gulamhusein A, Silva P, Cullen D et al (2020) Safety and feasibility of early single-dose mitomycin C bladder instillation after robot-assisted radical nephroureterectomy. BJU Int 126:739\u2013744. https:\/\/doi.org\/10.1111\/bju.15162","journal-title":"BJU Int"},{"key":"5434_CR17","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3233\/BLC-180174","volume":"4","author":"B Noennig","year":"2018","unstructured":"Noennig B, Bozorgmehri S, Terry R et al (2018) Evaluation of intraoperative versus postoperative adjuvant mitomycin C with nephroureterectomy for urothelial carcinoma of the upper urinary tract. Bladder Cancer 4:389\u2013394. https:\/\/doi.org\/10.3233\/BLC-180174","journal-title":"Bladder Cancer"},{"key":"5434_CR18","doi-asserted-by":"publisher","first-page":"737.e11","DOI":"10.1016\/j.urolonc.2020.05.002","volume":"38","author":"Y Freifeld","year":"2020","unstructured":"Freifeld Y, Ghandour R, Singla N et al (2020) Intraoperative prophylactic intravesical chemotherapy to reduce bladder recurrence following radical nephroureterectomy. Urol Oncol 38:737.e11-737.e16. https:\/\/doi.org\/10.1016\/j.urolonc.2020.05.002","journal-title":"Urol Oncol"},{"key":"5434_CR19","doi-asserted-by":"publisher","first-page":"1366982","DOI":"10.3389\/fsurg.2024.1366982","volume":"11","author":"S-F Chou","year":"2024","unstructured":"Chou S-F, Lin W-C, Chang H, Huang C-P (2024) Safety and oncological outcome of early intraoperative intravesicle mitomycin C vs. deferred instillation in patients receiving robot-assisted radical nephroureterectomy. Front Surg 11:1366982. https:\/\/doi.org\/10.3389\/fsurg.2024.1366982","journal-title":"Front Surg"},{"key":"5434_CR20","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.21037\/tau.2020.01.22","volume":"9","author":"NJ Kocher","year":"2020","unstructured":"Kocher NJ, Canes D, Bensalah K et al (2020) Incidence and preoperative predictors for major complications following radical nephroureterectomy. Transl Androl Urol 9:1786\u20131793. https:\/\/doi.org\/10.21037\/tau.2020.01.22","journal-title":"Transl Androl Urol"},{"key":"5434_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-015-0039-0","volume":"15","author":"MA Moriarty","year":"2015","unstructured":"Moriarty MA, Uhlman MA, Bing MT et al (2015) Evaluating the safety of intraoperative instillation of intravesical chemotherapy at the time of nephroureterectomy. BMC Urol 15:45. https:\/\/doi.org\/10.1186\/s12894-015-0039-0","journal-title":"BMC Urol"},{"key":"5434_CR22","doi-asserted-by":"publisher","first-page":"1229237","DOI":"10.21037\/tau-23-112","volume":"12","author":"MA Said","year":"2023","unstructured":"Said MA, Warner H, Stout TE et al (2023) Immediate gemcitabine bladder instillation following bladder closure during robotic-assisted radical nephroureterectomy: a multi-institutional report of feasibility and initial outcomes. Transl Androl Urol 12:1229237\u20131221237. https:\/\/doi.org\/10.21037\/tau-23-112","journal-title":"Transl Androl Urol"},{"key":"5434_CR23","doi-asserted-by":"publisher","first-page":"191.e1","DOI":"10.1016\/j.urolonc.2024.10.035","volume":"43","author":"S Moretto","year":"2025","unstructured":"Moretto S, Piccolini A, Gallioli A et al (2025) The role of intravesical chemotherapy following nephroureterectomy in upper tract urothelial carcinoma: a systematic review and meta-analysis. Urol Oncol 43:191.e1-191.e12. https:\/\/doi.org\/10.1016\/j.urolonc.2024.10.035","journal-title":"Urol Oncol"},{"key":"5434_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-022-01158-6","volume":"22","author":"S Lai","year":"2022","unstructured":"Lai S, Wu P, Liu S et al (2022) Presence of secondary bladder cancer following radical nephroureterectomy for upper tract urothelial carcinoma: characteristics, risk factors, and predictive value. BMC Urol 22:211. https:\/\/doi.org\/10.1186\/s12894-022-01158-6","journal-title":"BMC Urol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05434-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05434-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05434-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:02:13Z","timestamp":1791594133000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05434-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":24,"alternative-id":["5434"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05434-4","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"assertion":[{"value":"1 September 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}